N/A
N=38,514
Impact of Radiation Therapy on Breast Conservation in DCIS
DCIS
Bottom Line
View on ClinicalTrials.gov: NCT02248662 ↗Enrolled (actual)
38,514
Serious AEs
—
Results posted
Sep 2019
Primary outcome: Primary: Association Between Patient Characteristics and Three-Level Cluster of Treatment Intensity for Primary DCIS — 145; 115; 99; 0 Participants — p=<0.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- Female
- Sponsor
- Dana-Farber Cancer Institute
- Primary completion
- Jan 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Association Between Patient Characteristics and Three-Level Cluster of Treatment Intensity for Primary DCIS |
145; 115; 99; 0; 0; 0 | <0.05 sig |
Summary
Large regional variation exists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Although patients who do not receive initial radiotherapy for DCIS are candidates for subsequent BCS if they experience a second breast event, many undergo mastectomy instead.
Eligibility Criteria
This study used data from SEER and SEER-Medicare.
Data sourced from ClinicalTrials.gov (NCT02248662). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.